Young people have a strategy of anti-hepatitis B

• Author: admin
• Filed under: Hepatitis
• Date: Oct 30,2008

Chronic hepatitis B treatment is a long-term process, patients need to be able to have a certain degree of compliance to adhere to treatment, even the anti-viral interferon treatment, although its treatment of a fixed time, but it must insist on at least one year, The nucleoside analogues are longer, the treatment of nucleoside analogues do not have a fixed course, once the drug may need to take 5 years or even 10 years, and this requires our patients, especially young patients with the back of the way to go Long ago in the treatment of the psychological well-prepared is very important.
Adolescence is the treatment of chronic hepatitis B virus in the best period

Pathogenesis of hepatitis B from the point of view, the majority of patients with hepatitis B infection from mother to child transmission, an early age because of immune tolerance, the body’s immune system against hepatitis B virus for the performance of the “omission”, that is not clear, is This is due to the “omission”, there is no damage to the liver cells, there is no inflammation, so the time can not be given treatment, and in adolescence, the immune system to identify and remove viruses, we call this period For the removal of immunity, during this period we have adopted anti-retroviral therapy to strengthen the role of the removal of such immunity, the effect of treatment also will be the best.

Young patients with anti-viral treatment option to consider

Often in young patients with study, work in the best period fertility but also, so treatment must consider various aspects, such as the choice of treatment must take into account whether the recent birth of the needs of children, if necessary, first of all on Interferon should choose the anti-viral treatment, particularly for children, especially women, and this latest revision in 2007 of the United States of hepatitis B prevention and treatment guidelines also set out clear. Also need to consider other factors such as whether or not to adhere to long-term medication, and so on.

Young patients with anti-viral treatment to set a good state of mind

Chronic hepatitis B treatment is a long-term process, patients need to be able to have a certain degree of compliance to adhere to treatment, even the anti-viral interferon treatment, although its treatment of a fixed time, but it must insist on at least one year, The nucleoside analogues are longer, the treatment of nucleoside analogues do not have a fixed course, once the drug may need to take 5 years or even 10 years, and this requires our patients, especially young patients with the back of the way to go Long ago in the treatment of the psychological well-prepared is very important.

And clinicians to maintain good communication important

Young people are often in a job or career now at the start of the start-up phase, work, study very busy, and sometimes as a result will be busy with work and forget the treatment or follow-up, this is very dangerous. Hepatitis B treatment is very complicated and changes in the condition more often, the course of treatment may be a lot of side effects, if not in time to discover and deal with these side effects will not only affect the effectiveness of treatment, but also may affect patients Good health, if the drug without authorization, may be a serious rebound, there can not be expected consequences. As a result, the anti-viral treatment in the process of physician and good communication is very important.

In the face of the right treatment

Assessment of chronic hepatitis B treatment of many indicators of good or bad, can not simply look at an indicator of good or bad, we have a comprehensive view, we can not rely only on the level of aminotransferase, we can not simply look at the level of the virus, a simple two The negative indicators that can not be treated effectively, we must also look at the long-term response indicators such as the effect of the possible appearance of the e antigen serology or conversion of the antigen s serological conversion. e antigen serology convert the emergence of what we achieved the goal of a lasting remission, relapse may be very low, if the antigen s serological conversion, that treatment is very effective, have reached very close to the clinical cure The level of the patient’s prognosis will be greatly improved.

Related Reviews:

• Anti-hepatitis B pay attention to “individual” (0)
• Hepatitis B refractory to solve the “mystery” (0)
• Analysis of the likely negative hepatitis B (0)
• Hepatitis B treatment (0)